BTZ+TMZ 164 mg/m2 treated tumours exhibited reduced MGMT mRNA relative to untreated controls (by 55%) and relative to TMZ 164 mg/m2 (by 83%), providing proof-of-concept that efficacy of the combination treatment might be coincident with MGMT inhibition. Here, MGMT is linked to neoplasm.